NCT03231241 Analysis of Headache Chronification With Imaging, Deep Phenotyping, and Proteomics
| NCT ID | NCT03231241 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Chronic Daily Headache |
| Study Type | OBSERVATIONAL |
| Enrollment | 700 participants |
| Start Date | 2014-12-12 |
| Primary Completion | 2026-08-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 700 participants in total. It began in 2014-12-12 with a primary completion date of 2026-08-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Study is aimed at determining why some patients with episodic headache proceed to chronic daily or near daily headaches. The Investigators seek to discover differences in brain anatomy and function, composition of cerebrospinal fluid, blood products, genetics, and patient phenotypes that might help explain this process.
Eligibility Criteria
Inclusion Criteria: * Subjects must agree to sign informed consent. * Subject must be able to or at least with some help willing to complete online questionnaires in English . * Willing to comply with study instructions. * must speak and understand English Exclusion Criteria: \*Any neurological condition, at the discretion of the Principal Investigator (PI)
Contact & Investigator
Robert Cowan, MD, FAAN
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT03231241 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Daily Headache. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03231241 currently recruiting?
Yes, NCT03231241 is actively recruiting participants. Contact the research team at bharatis@stanford.edu for enrollment information.
Where is the NCT03231241 trial being conducted?
This trial is being conducted at Stanford, United States.
Who is sponsoring the NCT03231241 clinical trial?
NCT03231241 is sponsored by Stanford University. The principal investigator is Robert Cowan, MD, FAAN at Stanford University. The trial plans to enroll 700 participants.